These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22814819)

  • 1. Limitations of in vitro assessments of the drug interaction potential of botanical supplements.
    Markowitz JS; Zhu HJ
    Planta Med; 2012 Sep; 78(13):1421-7. PubMed ID: 22814819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting interactions between conventional medications and botanical products on the basis of in vitro investigations.
    Markowitz JS; von Moltke LL; Donovan JL
    Mol Nutr Food Res; 2008 Jul; 52(7):747-54. PubMed ID: 18324706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Safe and Effective Botanical Dietary Supplements.
    van Breemen RB
    J Med Chem; 2015 Nov; 58(21):8360-72. PubMed ID: 26125082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements.
    Gurley BJ
    Planta Med; 2012 Sep; 78(13):1478-89. PubMed ID: 22322396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow that botanical: Challenges and recommendations for assessing absorption, distribution, metabolism and excretion of botanical dietary supplements.
    Waidyanatha S; Ryan K; Roe AL; Jia W; Paine MF; Ferguson S; Gurley BJ; Welch K; Chow MSS; Devito M; Rider C
    Food Chem Toxicol; 2018 Nov; 121():194-202. PubMed ID: 30170118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.
    Sprouse AA; van Breemen RB
    Drug Metab Dispos; 2016 Feb; 44(2):162-71. PubMed ID: 26438626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment of botanicals and botanical preparations used as ingredients in food supplements: testing an European Food Safety Authority-tiered approach.
    Speijers G; Bottex B; Dusemund B; Lugasi A; Tóth J; Amberg-Müller J; Galli CL; Silano V; Rietjens IM
    Mol Nutr Food Res; 2010 Feb; 54(2):175-85. PubMed ID: 19960456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on chemical and biological research on botanical ingredients in dietary supplements.
    Pawar RS; Tamta H; Ma J; Krynitsky AJ; Grundel E; Wamer WG; Rader JI
    Anal Bioanal Chem; 2013 May; 405(13):4373-84. PubMed ID: 23322353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herb-drug interactions: challenges and opportunities for improved predictions.
    Brantley SJ; Argikar AA; Lin YS; Nagar S; Paine MF
    Drug Metab Dispos; 2014 Mar; 42(3):301-17. PubMed ID: 24335390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of garlic supplements and phytochemicals on the ADMET properties of drugs.
    Berginc K; Kristl A
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):295-310. PubMed ID: 22313151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance.
    Gurley BJ; Fifer EK; Gardner Z
    Planta Med; 2012 Sep; 78(13):1490-514. PubMed ID: 22565299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding the bad actor: Challenges in identifying toxic constituents in botanical dietary supplements.
    Roberts GK; Gardner D; Foster PM; Howard PC; Lui E; Walker L; van Breemen RB; Auerbach SS; Rider C
    Food Chem Toxicol; 2019 Feb; 124():431-438. PubMed ID: 30582954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botanical-drug interactions: a scientific perspective.
    de Lima Toccafondo Vieira M; Huang SM
    Planta Med; 2012 Sep; 78(13):1400-15. PubMed ID: 22864989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and biological characterization and clinical evaluation of botanical dietary supplements: a phase I red clover extract as a model.
    Piersen CE; Booth NL; Sun Y; Liang W; Burdette JE; van Breemen RB; Geller SE; Gu C; Banuvar S; Shulman LP; Bolton JL; Farnsworth NR
    Curr Med Chem; 2004 Jun; 11(11):1361-74. PubMed ID: 15180571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for risk assessment of botanical food supplements.
    Walker R
    Toxicol Lett; 2004 Apr; 149(1-3):187-95. PubMed ID: 15093264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico approach to safety of botanical dietary supplement ingredients utilizing constituent-level characterization.
    Little JG; Marsman DS; Baker TR; Mahony C
    Food Chem Toxicol; 2017 Sep; 107(Pt A):418-429. PubMed ID: 28698155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal hepatotoxicity.
    Stickel F; Patsenker E; Schuppan D
    J Hepatol; 2005 Nov; 43(5):901-10. PubMed ID: 16171893
    [No Abstract]   [Full Text] [Related]  

  • 18. Ensuring the safety of botanical dietary supplements.
    van Breemen RB; Fong HH; Farnsworth NR
    Am J Clin Nutr; 2008 Feb; 87(2):509S-13S. PubMed ID: 18258648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Botanical Safety Consortium: A public-private partnership to enhance the botanical safety toolkit.
    Mitchell CA; Dever JT; Gafner S; Griffiths JC; Marsman DS; Rider C; Welch C; Embry MR
    Regul Toxicol Pharmacol; 2022 Feb; 128():105090. PubMed ID: 34863907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "…Not Intended to Diagnose, Treat, Cure or Prevent Any Disease." 25 Years of Botanical Dietary Supplement Research and the Lessons Learned.
    Gurley BJ; Yates CR; Markowitz JS
    Clin Pharmacol Ther; 2018 Sep; 104(3):470-483. PubMed ID: 29882958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.